CAC Tied to Cardiovascular Risk During Radiation Therapy for NSCLC
MONDAY, Feb. 14, 2022 (HealthDay News) — The burden of coronary artery calcium (CAC) may help predict the risk for major adverse cardiovascular events (MACE) during radiation treatment for non-small cell lung cancer (NSCLC), according to a study pres…
Learn MoreVolume-Based Compensation Most Common Incentive for Doctors
MONDAY, Feb. 14, 2022 (HealthDay News) — The most common base compensation incentive component for primary care physicians (PCPs) and specialists is volume-based compensation, according to a study published online Jan. 28 in JAMA Health Forum.Rachel …
Learn MoreSurvival High With Lung Transplant for COVID-19-Associated ARDS
MONDAY, Feb. 14, 2022 (HealthDay News) — Lung transplantation is successful for patients with COVID-19-associated acute respiratory distress syndrome (ARDS), with high survival, according to a study published online Jan. 27 in the Journal of the Amer…
Learn MoreMany COVID-19 Home Test Users May Act on Quarantine Inappropriately
MONDAY, Feb. 14, 2022 (HealthDay News) — At-home COVID-19 self-test kit users who rely on the U.S. Food and Drug Administration-authorized instructions may not follow the U.S. Centers for Disease Control and Prevention quarantine recommendations, acc…
Learn MorePhysician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Feb. 7 to 11, 2022. This roundup includes the latest research news from journal studies and other trusted sour…
Learn MoreFDA Postpones Decision on Pfizer COVID-19 Vaccine for Under 5s
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. Food and Drug Administration announced Friday that it will postpone an advisory panel meeting that was slated for next week to weigh the Pfizer COVID-19 vaccine for use in young children.The FDA took …
Learn MoreFDA Approves New Antibody Drug to Fight Omicron Variant
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. Food and Drug Administration on Friday gave the nod for a new monoclonal antibody treatment that works against the omicron variant.The emergency use authorization for bebtelovimab is for the treatment…
Learn MoreMandatory COVID-19 Tests Lifted for Vaccinated Travelers to Britain
FRIDAY, Feb. 11, 2022 (HealthDay News) — Vaccinated travelers will no longer have to take COVID-19 tests when they enter Britain, officials announced Friday.British residents and visitors who have had at least two doses of an approved COVID-19 vaccin…
Learn MoreFDA Panel Rejects Lilly Cancer Drug Tested Only in China
FRIDAY, Feb. 11, 2022 (HealthDay News) — A new lung cancer drug that has only been tested in China was soundly rejected by an advisory panel to the U.S. Food and Drug Administration on Thursday.Known as sintilimab, the treatment is a type of immunoth…
Learn MoreU.S. Buys 600,000 Doses of New COVID-19 Treatment Still Awaiting FDA Approval
FRIDAY, Feb. 11, 2022 (HealthDay News) — The U.S. government has bought 600,000 doses of a new antibody drug called bebtelovimab that seems able to beat back the omicron variant, even though the medication has yet to be given the green light by the U…
Learn More